qedpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | QED Pharmaceuticals |
| Description | QED Pharmaceutical Services Quality and Ethics in Data --> Contact Us | Sitemap Home About Us Data Services Clinical Services Careers Collaborations Ne |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 67.195.197.24 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
qedpharma.com Valuation
|
US$334,034
Last updated: 2023-05-09 14:30:38
qedpharma.com has Semrush global rank of 31,686,333. qedpharma.com has an estimated worth of US$ 334,034, based on its estimated Ads revenue. qedpharma.com receives approximately 38,543 unique visitors each day. Its web server is located in United States, with IP address 67.195.197.24. According to SiteAdvisor, qedpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$334,034 |
| Daily Ads Revenue | US$309 |
| Monthly Ads Revenue | US$9,251 |
| Yearly Ads Revenue | US$111,002 |
| Daily Unique Visitors | 2,570 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| qedpharma.com. | A | 1200 | IP: 67.195.197.24 |
| qedpharma.com. | NS | 86400 | NS Record: yns2.yahoo.com. |
| qedpharma.com. | NS | 86400 | NS Record: yns1.yahoo.com. |
| qedpharma.com. | MX | 1200 | MX Record: 10 mx-biz.mail.am0.yahoodns.net. |
| qedpharma.com. | TXT | 1200 | TXT Record: i=320&m=geo-g8-mx2-p9 |
HtmlToTextCheckTime:2023-05-09 14:30:38
| QED Pharmaceutical Services Quality and Ethics in Data --> Contact Us | Sitemap Home About Us Data Services Clinical Services Careers Collaborations Newsroom Contact Us Latest News Research Indicates That Only One Per Cent Of Childrens BioMarin Initiates Phase 1 Clinical Study Of BMN 195 For Duchenne Muscular Dystrophy Ubiquitin-conjugating enzyme promotes chromosome missegregation and tumor formation Stem cell therapy holds promise as potential alternative to bone grafting operations Expertise Clinical Pharmacology Therapeutic Regulatory Data Management and Programming Welcome QED is a leading global Contract Research Organization (CRO), with offices in Hyderabad, India and Research Triangle Park, North Carolina, USA, specializing in conducting Phase I through IV Clinical Trials and other clinical and regulatory research services that cater to biotechnology and pharmaceutical product development. QED has the resources to implement Phase I through Phase IV clinical trials from |
HTTP Headers
HTTP/1.1 200 OK Date: Mon, 01 Nov 2021 00:24:25 GMT P3P: policyref="https://policies.yahoo.com/w3c/p3p.xml", CP="CAO DSP COR CUR ADM DEV TAI PSA PSD IVAi IVDi CONi TELo OTPi OUR DELi SAMi OTRi UNRi PUBi IND PHY ONL UNI PUR FIN COM NAV INT DEM CNT STA POL HEA PRE LOC GOV" Cache-Control: private Content-Type: text/html Age: 2 Connection: keep-alive Server: ATS |
qedpharma.com Whois Information
Domain Name: QEDPHARMA.COM Registry Domain ID: 1316815971_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2020-10-05T05:20:05Z Creation Date: 2007-11-03T18:04:34Z Registry Expiry Date: 2021-11-03T19:04:34Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T10:16:43Z <<< |